Medindia
Medindia LOGIN REGISTER
Advertisement

Increasing Competition From Other Biologic Agents Will Continue to Erode Enbrel's Dominance in the Psoriasis Drug Market

Wednesday, February 10, 2010 General News
Advertisement
Most Notably, Humira and Stelara Will Steal Share from Enbrel, According to New Findings from Decision Resources

For more information, contact:

Decision Resources

Gisselle Morales

781-296-2691

[email protected]

Decision Resources, Inc.

Christopher Comfort

781-296-2597

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close